Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Carisma Therapeutics, Inc. - Common Stock
(NQ:
CARM
)
1.130
-0.060 (-5.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
86,330
Open
1.210
Bid (Size)
1.130 (90)
Ask (Size)
1.240 (2)
Prev. Close
1.190
Today's Range
1.130 - 1.211
52wk Range
0.8000 - 7.144
Shares Outstanding
N/A
Dividend Yield
31.95%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Are Carisma Therapeutics Shares Surging Friday?
June 28, 2024
Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.
Via
Benzinga
Performance
YTD
-60.21%
-60.21%
1 Month
+4.63%
+4.63%
3 Month
-15.67%
-15.67%
6 Month
-55.34%
-55.34%
1 Year
-82.64%
-82.64%
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Via
InvestorPlace
In-Depth Examination Of 5 Analyst Recommendations For CARISMA Therapeutics
June 26, 2024
Via
Benzinga
The Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts
May 17, 2024
Via
Benzinga
The Latest Analyst Ratings for CARISMA Therapeutics
October 03, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About CARISMA Therapeutics
September 06, 2023
Via
Benzinga
Analyst Ratings for CARISMA Therapeutics
August 11, 2023
Via
Benzinga
CARM Stock Earnings: CARISMA Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q4 2023
April 01, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via
Benzinga
3 Top Under-$5 Stocks for Strong Gains and Positive Outlook
October 12, 2023
Via
InvestorPlace
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
October 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
July 06, 2023
Via
Benzinga
Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday
June 22, 2023
Via
Benzinga
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 22, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
April 14, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 23, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.